01 Strategies

SANTÉ INVESTS AT THE LEADING EDGE OF INNOVATION IN HEALTHCARE AND TECHNOLOGY. WE MANAGE APPROXIMATELY ONE BILLION DOLLARS OF CAPITAL IN TWO SEPARATE STRATEGIES.

Sante Ventures

Privately Held Companies

Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.

Sante Capital

Publicly Traded Securities

Santé Capital applies state-of-the-art data science and machine learning technologies to generate attractive risk-adjusted returns in a systematic liquid strategy.

ABK Biomedical
Apreo Health
Barologics
BeeKeeperAI
BioStable
CardiacBooster
CareHive
Clairity
Cryosa
Endogenex
Endovascular Engineering
Geneos Therapeutics
Glyscend
Healthcare Highways
HNI Healthcare
Iterion
Kela
Kestrel
Laminar
Libra
Lumos
Molecular Templates (mtem)
MycRX
RapidPulse, Inc
Reimagine Care
Reprieve
REVELOHEALTH
Ryme
Seeing Medicines
Sensorium
VS3 Medical, Inc.
Wave
02 Santé Ventures Strategy

We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.

View All Investments
03 Santé Capital Strategy

We leverage the latest advances in big data, machine learning, and natural language processing to systematically capture investment opportunities in a liquid portfolio of mispriced publicly traded securities.